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I.-10, originally termed cytokine synthesis inhibitory factor (CSIF), 2 was discovered as a product of Th2 cells that suppresses IFN-3, production by Thl cells (1-3). Ibl0 joins TGF-fl as one of the few lymphocyte suppressor factors to be purified and cloned (4, 5) . The mechanisms by which suppressor factors affect lymphocyte function are not well understood. Ibl0 inhibits Thl cells only in the presence of accessory cells, especially macrophages (mOb) (6) . This raises the possibility that II.-10 might act primarily on mOb to alter the balance between their lymphocyte-stimulating and lymphocyte-inhibiting secretory products (7) , thereby affecting lymphocytes secondarily.
As is the case for lymphocytes, only a f~w purified cytokines are known to suppress the function of mOb (8) (9) (10) (11) (12) (13) (14) . In fact, only two cytokines are known to block or reverse the activation of mouse mOb: TGF-3 (induding TGF-~-I, -2, and -3) and mOb deactivating factor (MDF) (8-10, 15-18; for review see reference 19 ). The present experiments were designed to test whether 1I.-10 is a new mOb deactivation factor, and if so, whether it mediates the mOb-deactivating effects of TGF~ or MDE 1 Christian Bogdan and Yoram Vodovotz contributed equally to the experiments described in this paper.
2 Abbreviations used in this paper. CSIF, cytokine synthesis inhibitory factor; MDF, macrophage deactivating factor; m~, macrophage; RNI, reactive nitrogen intermediates; ROI, reactive oxygen intermediates.
Materials and Methods
Mice. Female CD1 mice (8-12 wk old) were from the Charles River Breeding Laboratories (Wilmington, MA).
Cytokines and Other Reagents. Supernatants from COS7 cells transfected with mlL-10 eDNA (1,000 U/ml, where 1 U caused half-maximal response of the MC/9 mast cell line as described [20] ; LPS content at 100 U/ml < 10 pg/ml) and control supernatants from mock transfected cells (LPS content at a 1:10 dilution < 10 pg/ml) were kindly provided by Dr. K. Moore (DNAX, Palo Alto, CA; 1 MC/9 U/ml is equal to 1 CSIF U/ml, personal communication). MDF was purified from the culture supernatants of P815 mouse mastocytoma cells as described (10) or directly extracted from these cells following a similar procedure (Y. Vodovotz, C. Bogdan, and C. Nathan, unpublished results). A unit of MDF is defined as that amount of MDF in a final culture volume of 0.125 ml that causes 50% suppression of PMA-triggered mO HzO2-releasing capacity after a 48-h incubation (10) . rmlFN~ (protein concentration 1.1 mg/ml; sp act 5.2 x 106 U/mg; LPS content <10 pg/ml) and rmTNF-c~ (protein concentration 0.98 mg/ml; sp act 1.2 x 107 U/mg; LPS content <52 pg/ml) were kindly provided by Genentech (South San Francisco, CA). rhTGF~I was a gift of Amgen, Inc. (Thousand Oaks, CA). Ascites fluid containing a neutralizing rat IgM mAb against mlL-10 (SXC1 [21] ; LPS content <10 pg/ml at a 1:100 dilution) was a gift from Dr. S. Reed (Seattle, WA). A 1:1,000 dilution of this antibody preparation completely neutralized the effect of Ibl0 at concentrations ~100 U/nil and was used in all experiments. Purified rat IgM as an isotype control antibody was obtained from Calbiochem-Behring Corp. (La Jolla, CA). Turkey anti-TGF-B1 IgG and nonimmune turkey IgG were kindly provided by Dr. M. Sporn (National Cancer Institute, Bethesda, MD). LPS, prepared by phenol extraction from Esche-rickia coli Ol11:B4, was from List Biological Laboratories (Campbell, CA).
Mck Cultures. Periodate-and thioglycohte-didted m~ were harvested from the peritoneal cavity with c~MEM medium (JRI-I Biosciences, Cambridge, MA) and cultured as published (22) .
1-1202 Release Assay. 1.5 x 10 s Periodate-elicited peritoneal cells were triggered for HzOz release by PMA. HzO2 secretion/mg adherent cell protein was determined as described (10) .
Reactive Nitrogen Intermediates (RNI) Production and NO2-Determination. Monolayers ofthioglycolate-elicited mO were stimulated for RNI production by IFN-% IFN-3dTNF, or IFN-~//LPS for 48 h. Nitrite concentration in the cell-flee mO supernatants served as a reflection of nitric oxide production and was measured by the colorimetric Griess reaction as described (18, 22) .
TNF~c~ Production and TNF-oL Assay. Monolayers of thioglycalate-elicited mO were obtained by seeding the ceils in 24-well plastic tissue culture plates (Costar, Cambridge, MA) at 10~/well (final volume of 0.5 ml) for 2-3 h at 37~ in 5% COz/95% air. Nonadherent cells were removed by three washes with PBS (37~ and the monolayers were then stimulated with LPS (+ rmIFN-3,) either in the presence or absence of rmIL-10 as indicated in the text. 20 h later, the supernatants were harvested and stored at -20~ The TNF-o~ content of the test supernatants was determined in a bioassay with the highly specific and sensitive subdone 13 of the WEH1164 fibrosatcoma line (23) (kindly provided by Dr. S. Kunkel, Ann Arbor, MI, with permission of Dr. T. Espevik, Trondheim, Norway) as published previously (24) . Data from at least 10 serial twofold dilutions per supernatant were subjected to probit analysis using a rmTNF-c~ standard curve as described (25) . Finally, the fold suppression of TNF release in the test supernatants was determined [(ng/ml TNF in medium control)/(ng/ml TNF in test supernatant)]. Use ofa polyclonal rabbit anti-TNF-ot antiserum (Genzyme, Boston, MA) demonstrated that the cytotoxic activity was completely dependent on TNF-oc SDS-PAGE and Western Blot. Ibl0-containing and mock control COS cell supematants and partially purified MDF were separated on 20% SDS-PAGE and transferred to nitrocellulose membranes (26, 27) .
Protein Synthesis. Monolayers (2 x 106/we11) of periodateelicited m~ were incubated for 48 h in complete ILPMI 1640 in the presence or absence of rmIL-10. During the last 6 h of incubation, the medium was exchanged for methionine-free RPMI 1640 with 1% FCS (Gibco, NY), and 50/~Ci [3sS]L-methionine (> 1,000 Ci/mmol; Amersham Corp., South Clearbrook, IL) was added per 2 x 106 mqL The cells were then washed and lysed in 1% triton X-100 and processed for determination of radiolabded protein as described (15) . Additional aliquots of the lysates were subjected to SDS-PAGE autoradiography.
Results
TGF-B and MDF can prevent mO from releasing all three of their major cytotoxic products: TNF-c~ (28, and Bogdan, C., Y. Vodovotz, and C. Nathan, manuscript in preparation), reactive oxygen intermediates (ROI) (8, 10, (15) (16) (17) , and RNI (18, 29) . Accordingly, we tested the effects of IL-10 in each of these assays.
Suppression of TNF-ol Release. IL-10 was an exceedingly potent inhibitor of m~ TNF-o~ release ( Fig. 1; Fig. 2 A) . The inhibitory effect was concentration dependent, reaching its plateau upon exposure of m~ to 10 U/m1 II.-10, which cause 32.4 (_+ 2.8)-fold (97%) suppression (mean _+ SEM of three experiments) of mO TNF-c~ release induced by 0.5 #g/ml LPS. 50% suppression required only 0.044 _+ 0.031 U/ml (mean _+ SD from four experiments). Preincubation of the m~ with Ibl0 before stimulation by LPS was not necessary. Anti-II.-10 mAb abolished the suppression afforded by IL-10-containing COS cell supernatant (Fig. 1 B) , whereas a rat IgM control antibody failed to do so (not shown). Mocktransfected COS cell supernatant had no effect (Fig. 1 B) . IL-10 abolished TNF-ol release induced by LPS at concentrations of 0.25 or 0.5 #g/ml (Fig. 1) , I or 10 #g/ml (not shown), or when TNF-c~ release was induced by the combination of LPS (0.25 #g/ml) and IFN-~/(10 or 20 ng/ml) (Fig. 1 A) .
In control experiments, ID10 did not stimulate the indicator cells in the TNF bioassay; protect them from inhibition by .
•TNF exogenous TNFc~; nor induce mS to release a factor that could block the action of TNF-ot (not shown).
Suppression of 1-1202 Release.
Concentrations of IL-10 50-100-fold higher than those suppressing TNF-ot release suppressed the ability of PMA-triggered m~6 to release H2Oz (ICso = 3.7 _+ 1.8 U/m1, mean _+ SD, three experiments) (Fig. 2 B) . The range of suppression caused by 10 U/ml IL-10 was 55-79% with a mean (_+ SEM) of 65% (_+ 4.1; four experiments). This action of II~10-containing COS cell supernatant was abolished by anti-Ibl0 mAb and was lacking in mock-transfected COS cell supernatant (Fig. 3) .
Relation between 11.,I0 and MDF or TGF- [3. Since suppression of mouse peritoneal rock H202 releasing capacity has been the cardinal assay for characterization of MDF (10, (15) (16) (17) , it was important to test whether MDF consists in, or acts through the induction of, IL-10. As shown in Fig. 3 , antiIbl0 mAb had no effect on the respiratory burst-suppressing action of MDF. Moreover, anti-Ibl0 mAb immunoblotted IL-10 in COS cell supernatant, but not a preparation of semipurified MDF containing a twofold higher bioactivity as determined in the H202 release assay (Fig. 4) .
Likewise, the suppressive action of TGFq3 on the mck respiratory burst (8, 17) or TNF-ot release (28) was unaffected by anti-IL-10 mAb (not shown). Finally, abs that neutralize TGF-B but not MDF in the H202 release assay (10) had no effect on suppression by IL-10 ( Fig. 5) . Anti-MDF abs are not yet available.
Effect of lL, lO on RNI Release. The above results indicated that Ibl0 appears to act independently of TGF43 and MDF. Thus, the spectrum of action of IL-10 on m~ may differ from that of TGF-B and MDF. Indeed, unlike TGF-B and MDF (18) , IL-10 only variably and weakly inhibited the induction of RNI release by IFN-3~ (range of suppression by 10 U/ml in six experiments: 0-60%; mean _+ SEM = 37 _+ 15%) and was unable to suppress RNI release induced by the combination of IFN-3, and TNF-c~ (Fig. 2 C) . Higher concentrations of IL-10 (100 U/m1) did not further increase the suppression of RNI release (three experiments; data not shown). As found for MDF and TGF43, Ibl0 also failed to inhibit RNI release induced by the combination of IFN-3' plus LPS (Fig. 2 C) .
Effect of ll.,IO on mc~ Protein Synthesis. The selectivity of Ibl0 effects on m~ was further demonstrated by its inability to alter the incorporation of 3SS-methionine into protein, or to affect the overall pattern of protein synthesis as evaluated by one-dimensional SDS-PAGE (not shown).
Discussion
IL-10 appears to be even more potent as a suppressor of mS TNF-c~ release than as a suppressor of Thl cell IFN-3, synthesis (1). A concentration of II.-10 (1 U/ml) that almost completely suppressed mS TNF-c~ release (95.4% supprestreated cultures with those of the medium control. Data represent mean values (+ SEM) of three (TNF-ot release), four (H202 release) or five (NO2-release) experiments, respectively. sion) had little effect on H202 release (42% suppression) and on the secretion of R.NI (36% suppression). TNF-c~ is a potent growth and differentiation factor for mouse T cells (30) (31) (32) . In contrast, KOI and RNI suppress lymphocyte function (33-35). Thus, activated mS exposed to low concentrations of I1-10 are likely to produce ROI and RNI but not TNF-a, and thus may display a suppressor phenotype toward lymphocytes. This may contribute to the CSIF activity of I1-10. On the other hand, at higher concentrations (10 U/ml), Ibl0 markedly suppressed not only mS TNF-o~ release but also the release of ROI. Finally, although Ibl0 only weakly suppressed RNI release induced by IFN-7, II-10 might be more effective at suppressing I~NI release indirectly in situations where RNI release depends on an autocrine action of TNF-o~. Ingestion of pathogens is a strong stimulus for mS to release TNF-ol (24, 36) , which in turn helps to induce RNI by interacting synergistically with IFN-7 (22, 37) . Since I~OI, RNI, and TNF-a are among the major antimicrobial (for review see references 38 and 39) and antitumor products of mS (for review see reference 40), a second phenotype of the IL-10-treated mS may be that of a cell permissive for the growth of pathogens and tumor cells. I1.10, therefore, may suppress the antimicrobial and tumoricidal function of mS in two ways: first, indirectly through inhibition of IFN-7 production by Thl cells, which then impairs mS activation; and second, directly through deactivation even in the presence of IFN-7.
I1.10's actions on mS function were selective and nontoxic. At the same time that II-10 abolished TNF-a release and decreased H202 release, it had only little effect on their release of RNI. I1-10 did not affect the number of mS remaining adherent to vigorously washed plates (Fig. 3) , their overall synthesis of protein, nor their synthesis of major proteins.
I1-10, TGF-fl, and MDF appeared to act independendy, since abs that neutralized either I1-10 or TGF-fl had no effect on the actions of the other two proteins in the same assays. Although MDF remains to be cloned, it appears to be distinct from 11-10 by the following criteria. MDF migrates at ~13 kD on denaturing SDS-PAGE and is purified on the basis of its acid stability (10), while II.,10 migrates at 16-21 Periodate-elicited cells (1.5 • 10S/well) were cultured in medium alone (control) or in TGF-31 (10 ng/ml) or in Ib10 (10 U/ml), in the presence of preimmune (PS) or immune (IS) anti-TGF-/51 antiserum or in the absence of antiserum (no Ab). After 48 h, HzOz release was triggered and the adherent cell protein determined. Data represent mean (• SD) from triplicate cultures of a representative experiment.
kD on SDS-PAGE and is acid labile (2) . MDF (Vodovotz, Y., C. Bogdan, and C. Nathan, manuscript in preparation) but not II.-10 inhibits lymphocyte proliferation (1, 2, 41). Moreover, MDF is much more potent in suppressing RNI release (18) . Like TGF-/3 (8) but unlike MDF (10, 15), IL-10 tends to cause adherent m~ to round up in culture (not shown). Finally, anti-IL-10 mAb neither neutralizes nor immunoblots MDF.
Several cytokines activate mqb in ways that are overlapping but distinct, giving rise to diverse phenotypes. The same can now be said of cytokines that deactivate m~.
